Renishaw plc (RNSHF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Renishaw plc (RNSHF) es una empresa del sector Technology valorada en 0. La acción obtiene una puntuación de 54/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026Perfil Tecnológico y Posición Competitiva de Renishaw plc (RNSHF)
Renishaw plc, a UK-based engineering and scientific technology firm, delivers metrology and healthcare solutions worldwide. With a focus on precision measurement and process control, Renishaw serves diverse sectors including aerospace, automotive, and healthcare, leveraging its innovative product portfolio and global distribution network to maintain a competitive edge.
Tesis de Inversión
Renishaw presents a compelling investment case based on its diverse product portfolio and global market reach. With a P/E ratio of 37.88 and a profit margin of 10.1%, the company demonstrates solid financial performance. The dividend yield of 2.02% provides an additional incentive for investors. Key growth drivers include expanding applications of additive manufacturing and increasing demand for precision measurement in various industries. However, potential risks include economic downturns affecting capital expenditures and competition from other technology providers. The company's beta of 0.87 suggests lower volatility compared to the overall market.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $4.29 billion, reflecting a significant presence in the technology sector.
- Gross margin of 52.1%, indicating strong pricing power and efficient cost management.
- Dividend yield of 2.02%, offering a steady income stream for investors.
- Profit margin of 10.1%, showcasing profitability in a competitive market.
- Beta of 0.87, suggesting lower volatility compared to the broader market.
Competidores y Pares
Fortalezas
- Strong technological expertise in metrology and healthcare.
- Diverse product portfolio serving multiple industries.
- Global distribution and service network.
- Reputation for quality and precision.
Debilidades
- Dependence on capital expenditures in cyclical industries.
- Exposure to currency fluctuations.
- Limited presence in certain emerging markets.
- Relatively high P/E ratio compared to some competitors.
Catalizadores
- Upcoming: Launch of new additive manufacturing systems in Q4 2026, targeting the aerospace and automotive industries.
- Ongoing: Increasing adoption of Renishaw's healthcare products, particularly neurosurgical robots, in hospitals worldwide.
- Ongoing: Expansion of metrology solutions in emerging markets, driven by growing manufacturing sectors.
- Upcoming: Strategic partnerships with technology companies to enhance product offerings in Q2 2027.
- Ongoing: Continued investment in research and development to drive innovation and maintain competitive edge.
Riesgos
- Potential: Economic downturns affecting capital expenditures in key industries.
- Ongoing: Competition from other technology providers in metrology and healthcare.
- Potential: Disruptive technologies rendering existing products obsolete.
- Ongoing: Exposure to currency fluctuations impacting financial results.
- Potential: Regulatory changes in healthcare and manufacturing affecting product approvals and market access.
Oportunidades de crecimiento
- Expansion in Additive Manufacturing: Renishaw can capitalize on the growing additive manufacturing market, projected to reach $55.8 billion by 2027. By developing advanced additive manufacturing systems and materials, Renishaw can serve industries such as aerospace and healthcare, offering customized solutions and gaining a competitive edge. This expansion requires continued investment in research and development and strategic partnerships.
- Penetration of Healthcare Market: The healthcare market presents a significant growth opportunity for Renishaw, particularly in neurosurgical robotics and customized implants. As the demand for precision medicine and minimally invasive procedures increases, Renishaw's innovative healthcare products can gain wider adoption. The global neurosurgical robotics market is expected to reach $2.5 billion by 2028, providing a substantial market for Renishaw's products.
- Advancements in Metrology Solutions: Renishaw can leverage its expertise in metrology to develop advanced measurement and inspection solutions for various industries. The increasing demand for precision and quality control in manufacturing drives the need for innovative metrology products. The global metrology market is expected to reach $14.5 billion by 2025, offering a significant opportunity for Renishaw to expand its market share.
- Geographic Expansion in Emerging Markets: Emerging markets, such as Asia-Pacific and Latin America, offer significant growth potential for Renishaw. By establishing a stronger presence in these regions and tailoring products to local needs, Renishaw can tap into new customer bases and increase revenue. The growth in manufacturing and healthcare sectors in these regions will drive demand for Renishaw's products and services.
- Strategic Partnerships and Acquisitions: Renishaw can pursue strategic partnerships and acquisitions to expand its product portfolio and market reach. Collaborating with other technology companies and acquiring complementary businesses can enhance Renishaw's capabilities and strengthen its competitive position. These partnerships can provide access to new technologies, markets, and customers, accelerating Renishaw's growth.
Oportunidades
- Expansion in additive manufacturing market.
- Penetration of healthcare market with innovative products.
- Geographic expansion in emerging markets.
- Strategic partnerships and acquisitions.
Amenazas
- Economic downturns affecting capital spending.
- Competition from other technology providers.
- Disruptive technologies.
- Regulatory changes in healthcare and manufacturing.
Ventajas competitivas
- Technological expertise in metrology and additive manufacturing.
- Strong brand reputation for quality and precision.
- Global distribution and service network.
- Proprietary technology and intellectual property.
- Diverse product portfolio serving multiple industries.
Acerca de RNSHF
Renishaw plc, founded in 1973 and headquartered in Wotton-under-Edge, United Kingdom, is an engineering and scientific technology company with a global presence. The company designs, manufactures, distributes, sells, and services a range of metrology and healthcare products. Its metrology offerings include co-ordinate measuring machine (CMM) products, machine tool probe and software, performance measurement systems, gauging systems, fixtures, and styli for touch probe systems. Additionally, Renishaw provides interferometric laser, magnetic, and optical encoders, additive manufacturing systems, and vacuum casting machines. In the healthcare sector, Renishaw offers dental scanners, neurosurgical robots and accessories, neurosurgical planning software, drug delivery systems, Raman microscopes, craniomaxillofacial customized implants, analysers, and hybrid Raman systems. The company also provides asset financing and travel agency services. Renishaw serves a wide array of industries, including aerospace, agriculture, automotive, construction, consumer electronics, healthcare, power generation, resource exploration, energy, heavy industry, medical, and precision manufacturing, as well as scientific, research, and analysis sectors. Renishaw's commitment to innovation and precision has established it as a key player in the global technology landscape.
Qué hacen
- Designs and manufactures metrology products, including CMMs and machine tool probes.
- Develops and distributes healthcare products, such as dental scanners and neurosurgical robots.
- Offers additive manufacturing systems for various industries.
- Provides encoders for motion control applications.
- Supplies Raman microscopes for scientific research and analysis.
- Offers customized implants for craniomaxillofacial surgery.
- Provides asset financing and travel agency services.
Modelo de Negocio
- Sales of metrology products and systems to manufacturing industries.
- Revenue from healthcare product sales, including dental scanners and surgical robots.
- Income from additive manufacturing systems and related services.
- Service and maintenance contracts for installed equipment.
- Asset financing and travel agency services.
Contexto de la Industria
Renishaw operates in the hardware, equipment, and parts industry within the broader technology sector. The industry is characterized by continuous innovation and increasing demand for precision and automation. Market trends include the adoption of additive manufacturing, advancements in metrology, and the integration of technology in healthcare. Renishaw competes with companies like APELY (Applied Materials Inc.) and ASUUY (ASML Holding NV), focusing on niche markets and specialized solutions. The global market for precision measurement and additive manufacturing is expected to grow, driven by demand from industries like aerospace and healthcare.
Clientes Clave
- Aerospace industry for precision measurement and manufacturing.
- Automotive industry for quality control and automation.
- Healthcare sector for dental and surgical applications.
- Consumer electronics industry for precision manufacturing.
- Research and scientific institutions for analysis and measurement.
Finanzas
Gráfico e información
Precio de la acción de Renishaw plc (RNSHF): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Lows On Thursday
· 27 feb 2020
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para RNSHF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para RNSHF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de RNSHF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria Hardware, Equipment & PartsLiderazgo: William Ernest Lee
Chief Executive Officer
William Ernest Lee serves as the Chief Executive Officer of Renishaw plc. His background includes extensive experience in the engineering and technology sectors. Prior to his role at Renishaw, he held various leadership positions in technology-driven companies, focusing on strategic development and operational efficiency. He is known for his expertise in driving innovation and expanding market presence. Lee's educational background includes advanced degrees in engineering and business management, providing him with a strong foundation for leading a global technology company.
Historial: Under William Ernest Lee's leadership, Renishaw has focused on expanding its presence in key markets and investing in research and development. Key achievements include the launch of innovative products in the healthcare and additive manufacturing sectors. He has also overseen strategic acquisitions and partnerships to enhance Renishaw's capabilities and market reach. His tenure has been marked by a commitment to technological innovation and sustainable growth.
Información del mercado OTC de RNSHF
The OTC Other tier represents the lowest tier of the OTC market, indicating that Renishaw plc (RNSHF) may have limited financial disclosure and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies in this tier may not meet the minimum listing requirements of higher-tier OTC markets or national exchanges. Investing in OTC Other stocks involves higher risks due to the potential lack of transparency and regulatory scrutiny. Investors should conduct thorough due diligence before considering an investment in RNSHF.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Lower liquidity and trading volumes.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's business model and revenue streams.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Established operating history in the engineering and scientific technology sector.
- Global presence and diverse product portfolio.
- Reputation for quality and innovation.
- Presence of a recognized CEO and management team.
- Dividend payments indicating financial stability.
Acciones de Renishaw plc: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar RNSHF?
Renishaw plc (RNSHF) actualmente tiene una puntuación IA de 54/100, indicando puntuación moderada. Fortaleza clave: Strong technological expertise in metrology and healthcare.. Riesgo principal a monitorear: Potential: Economic downturns affecting capital expenditures in key industries.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de RNSHF?
RNSHF actualmente puntúa 54/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de RNSHF?
Los precios de RNSHF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre RNSHF?
La cobertura de analistas para RNSHF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en RNSHF?
Las categorías de riesgo para RNSHF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Economic downturns affecting capital expenditures in key industries.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de RNSHF?
La relación P/E para RNSHF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está RNSHF sobrevalorada o infravalorada?
Determinar si Renishaw plc (RNSHF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de RNSHF?
Renishaw plc (RNSHF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is based on available information and may be subject to change.
- OTC market data may have limited accuracy and availability.
- AI analysis is pending and may provide further insights.